Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Psychostimulant effect of levodopa: reversing sensitisation is possible.

Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18.

PMID:
22991345
[PubMed - indexed for MEDLINE]
2.

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.

Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P.

Brain. 2012 May;135(Pt 5):1463-77. doi: 10.1093/brain/aws078. Epub 2012 Apr 15.

PMID:
22508959
[PubMed - indexed for MEDLINE]
Free Article
3.

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P.

Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17.

PMID:
20237128
[PubMed - indexed for MEDLINE]
Free Article
4.

SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.

Nunta-Aree S, Sitthinamsuwan B, Boonyapisit K, Pisarnpong A.

J Med Assoc Thai. 2010 May;93(5):529-40.

PMID:
20524438
[PubMed - indexed for MEDLINE]
5.

Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon.

Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, Delval A, Blond S, Defebvre L, Destée A, Krystkowiak P.

J Neurol. 2009 Oct;256(10):1736-41. doi: 10.1007/s00415-009-5195-2. Epub 2009 Jun 18.

PMID:
19536584
[PubMed - indexed for MEDLINE]
6.

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.

N Engl J Med. 2003 Nov 13;349(20):1925-34.

PMID:
14614167
[PubMed - indexed for MEDLINE]
Free Article
7.

Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.

Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L.

Brain. 2011 Jul;134(Pt 7):2074-84. doi: 10.1093/brain/awr121. Epub 2011 Jun 11.

PMID:
21666262
[PubMed - indexed for MEDLINE]
Free Article
8.

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, Moro E, Benabid AL, Pollak P.

Mov Disord. 2003 May;18(5):524-30.

PMID:
12722166
[PubMed - indexed for MEDLINE]
9.

Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease.

Schneider F, Habel U, Volkmann J, Regel S, Kornischka J, Sturm V, Freund HJ.

Arch Gen Psychiatry. 2003 Mar;60(3):296-302.

PMID:
12622663
[PubMed - indexed for MEDLINE]
10.

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.

Moro E, Esselink RJ, Benabid AL, Pollak P.

Brain. 2002 Nov;125(Pt 11):2408-17.

PMID:
12390968
[PubMed - indexed for MEDLINE]
Free Article
11.

Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.

Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Ogawa K, Mizutani T.

J Neurosurg. 2001 Aug;95(2):213-21.

PMID:
11780890
[PubMed - indexed for MEDLINE]
12.

Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.

Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E.

Arch Neurol. 2011 Dec;68(12):1550-6. doi: 10.1001/archneurol.2011.182. Epub 2011 Aug 8.

PMID:
21825213
[PubMed - indexed for MEDLINE]
13.

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.

N Engl J Med. 1998 Oct 15;339(16):1105-11.

PMID:
9770557
[PubMed - indexed for MEDLINE]
Free Article
14.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
[PubMed - indexed for MEDLINE]
Free Article
15.

Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.

Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, Ferrer E.

Arch Neurol. 2000 Jul;57(7):983-8.

PMID:
10891980
[PubMed - indexed for MEDLINE]
16.

Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation lead. Case report.

Alterman RL, Shils JL, Gudesblatt M, Tagliati M.

Neurosurg Focus. 2004 Jul 15;17(1):E6.

PMID:
15264775
[PubMed - indexed for MEDLINE]
17.

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.

Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A.

Brain. 2010 Sep;133(9):2664-76. doi: 10.1093/brain/awq221.

PMID:
20802207
[PubMed - indexed for MEDLINE]
Free Article
18.

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.

Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G.

Mov Disord. 2006 Jun;21 Suppl 14:S290-304. Review.

PMID:
16892449
[PubMed - indexed for MEDLINE]
19.

Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation.

Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A.

Mov Disord. 2009 Mar 15;24(4):557-63. doi: 10.1002/mds.22390.

PMID:
19097175
[PubMed - indexed for MEDLINE]
20.

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ.

Arch Neurol. 2006 Jul;63(7):951-5.

PMID:
16831963
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk